UNICANCER
🇧🇷Brazil
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.unicancer.fr
Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 80
- Registration Number
- NCT06680596
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, France
Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 40
- Registration Number
- NCT06653777
- Locations
- 🇫🇷
Institut Curie, Paris, France
Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 700
- Registration Number
- NCT06625970
Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-09-23
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 2454
- Registration Number
- NCT06606730
Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 72
- Registration Number
- NCT06529718
- Locations
- 🇫🇷
Institute Mutualiste Montsouris, Paris, France
🇧🇪Cliniques universitaires Saint-Luc, Brussels, Belgium
🇬🇧University College London, London, United Kingdom
Blood Biomarkers Based Screening for HPV-driven OPC
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 10000
- Registration Number
- NCT06528353
Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 198
- Registration Number
- NCT06524583
- Locations
- 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
🇫🇷Institut Paoli Calmettes, Marseille, France
🇫🇷Centre Francois Baclesse, Caen, France
Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-17
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 472
- Registration Number
- NCT06505018
- Locations
- 🇫🇷
Groupe Hospitalier de La Rochelle-Ré-Aunis, La Rochelle, France
🇫🇷Institut de Cancérologie des Hauts-de-France (ICHF), Arras, France
🇫🇷CH Aunay-Bayeux, Bayeux, France
Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-11
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 500
- Registration Number
- NCT06496581
- Locations
- 🇫🇷
CHRU Tours, Tours, France
🇫🇷Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France
🇫🇷Institut de Cancérologie de l'Ouest, Saint-Herblain, France
Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 400
- Registration Number
- NCT06475352
© Copyright 2024. All Rights Reserved by MedPath